Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

One shot for two viruses: new combo vaccine trial shows promise

NCT ID NCT06864143

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 29 times

Summary

This study tested a new combination vaccine called mRNA-1083 that aims to protect against both flu and COVID-19 in a single shot. About 1,320 adults aged 18 to 64 took part. Researchers measured the immune response and checked for side effects to see if the combo vaccine works as well as separate vaccines.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Artemis Research (Headlands)

    San Diego, California, 92103, United States

  • Clinical Research Atlanta (Headlands)

    Stockbridge, Georgia, 30281, United States

  • DM Clinical Research - Bellaire

    Houston, Texas, 77081, United States

  • DM Clinical Research - Boston

    Brookline, Massachusetts, 02446, United States

  • DM Clinical Research - Chicago

    Melrose Park, Illinois, 60160, United States

  • DM Clinical Research - Detroit

    Southfield, Michigan, 48076, United States

  • DM Clinical Research - Philadelphia

    Philadelphia, Pennsylvania, 19107, United States

  • DM Clinical Research - Tomball

    Tomball, Texas, 77375, United States

  • Headlands Research Scottsdale

    Scottsdale, Arizona, 85260, United States

  • Trial Management Associates, LLC

    Wilmington, North Carolina, 28403, United States

  • Trial Management Associates, LLC

    Myrtle Beach, South Carolina, 29572, United States

  • Velocity Clinical Research, Boise

    Meridian, Idaho, 83642, United States

  • Velocity Clinical Research, Cincinnati, Mt. Auburn

    Cincinnati, Ohio, 45219, United States

  • Velocity Clinical Research, Cincinnati, Springdale

    Cincinnati, Ohio, 45246, United States

  • Velocity Clinical Research, Lafayette

    Lafayette, Louisiana, 70809, United States

  • Velocity Clinical Research, Norfolk

    Norfolk, Nebraska, 68701, United States

  • Velocity Clinical Research, Rockville

    Rockville, Maryland, 20854, United States

Conditions

The condition(s) this trial relates to.

COVID-19 influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.